HealthEquity (HQY) vs Remitly Global (RELY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Remitly Global (RELY) has outperformed HealthEquity (HQY) over the past year, gaining 47.7% versus a gain of 1.0%. Over five years, HQY leads with a +47.3% price change compared with -41.5% for RELY. HealthEquity is the larger company by market cap ($7.70 billion vs $4.98 billion), about 1.5 times the size, while Remitly Global is growing revenue faster (+29.4% vs +9.5%).
On valuation, Remitly Global trades at a lower forward P/E (14.6x vs 16.9x for HealthEquity). HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus 4.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQY | RELY |
|---|---|---|
| Share price | $93.05 | $23.52 |
| Market cap | $7.70B | $4.98B |
| 1-day change | +1.25% | +2.57% |
| YTD return | +1.57% | +70.43% |
| 1-year return | +1.04% | +47.74% |
| 5-year return | +47.35% | -41.49% |
| P/E ratio (TTM) | 33.59 | 17.04 |
| Forward P/E | 16.92 | 14.56 |
| EPS (TTM) | $2.77 | $1.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.31B | $1.64B |
| Revenue growth (YoY) | +9.47% | +29.37% |
| Net income (latest FY) | $215.20M | $67.93M |
| Gross margin | 69.52% | — |
| Operating margin | 24.55% | 4.74% |
| Net margin | 16.38% | 4.15% |
| 52-week high | $107.62 | $27.48 |
| 52-week low | $72.76 | $12.08 |
| Distance from 52-week high | -13.54% | -14.41% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +28.24% | +36.52% |
| Average volume | 841.36K | 3.52M |
| Shares outstanding | 82.72M | 211.68M |
| Employees | 2,814 | 3,200 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RELY has outperformed HQY by 46.7 percentage points over the past year.
- HealthEquity trades at a higher earnings multiple (33.6x vs 17.0x trailing P/E).
- HealthEquity is more profitable, keeping 16.4 cents of every revenue dollar as net income versus 4.2 cents for Remitly Global.
- Remitly Global grew revenue faster in its latest fiscal year (+29.37% vs +9.47%).
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
About Remitly Global
RELY stock →Remitly Global, Inc., a cross-border payment company engages in the provision of digital financial services in the United States, Canada, and internationally. It offers cross-border remittances and complementary financial services through mobile application and website.
Consumer Discretionary · Business Services · 3,200 employees
HQY vs RELY FAQ
Which is bigger, HealthEquity or Remitly Global?
HealthEquity (HQY) is larger, with a market capitalization of $7.70B compared with $4.98B for Remitly Global (RELY).
Which stock has performed better over the past year, HQY or RELY?
RELY returned +47.74% over the past 12 months, compared with +1.04% for HQY (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HQY or RELY?
RELY has the lower trailing P/E at 17.0, versus 33.6 for HQY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are HealthEquity and Remitly Global in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.